Bioactive coating of titanium surfaces with recombinant human β-defensin-2 (rHuβD2) may prevent bacterial colonization in orthopaedic surgery

J Bone Joint Surg Am. 2011 May 4;93(9):840-6. doi: 10.2106/JBJS.I.01738.

Abstract

Background: A promising strategy to prevent infections around orthopaedic titanium implants is to use naturally occurring cationic antimicrobial peptides (CAMPs) such as the human β-defensin-2 as antibacterial coatings. Human antimicrobial peptides represent a part of the innate immune system and have a broad antimicrobial spectrum against bacteria, fungi, and viruses.

Methods: In the present study, titanium surfaces were functionalized by four different self-assembled monolayers (SAMs) forming methoxy silanes: (1) hexadecyltrimethoxysilane, (2) dimethoxymethyloctylsilane, (3) allyltrimethylsilane, and (4) 3-aminopropyltrimethoxysilane. In addition, calf skin type-I collagen was cross-linked to the SAM surface 3-aminopropyltrimethoxysilane by means of two different treatments: (1) N-hydroxysuccinimide and (2) glutaraldehyde. The functionalized titanium surfaces were coated with recombinant human β-defensin-2 (rHuβD2), an antimicrobial peptide, and were tested for antibacterial activity against Escherichia coli. The release of rHuβD2 was quantified by means of enzyme-linked immunosorbent assay (ELISA).

Results: The coating of functionalized titanium surfaces with rHuβD2 was successful. Recombinant HuβD2 was eluted from the titanium surfaces continuously, yielding antimicrobial activity up to several hours. Antimicrobial activity with a killing rate of 100% was observed for all functionalized titanium surfaces after two hours of incubation. The dimethoxymethyloctylsilane-functionalized titanium surface delivered 0.65 μg of rHuβD2 after six hours with a 60% bacterial killing rate. The silane-functionalized surfaces exhibited a faster release of antimicrobially active rHuβD2 compared with collagen modifications.

Conclusions: Natural antibiotics such as rHuβD2 integrated into the metal surface of titanium implants may be a promising tool to prevent and control infections around orthopaedic implants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimicrobial Cationic Peptides / administration & dosage
  • Antimicrobial Cationic Peptides / pharmacology*
  • Bone Nails*
  • Coated Materials, Biocompatible*
  • Collagen
  • Escherichia coli / drug effects*
  • Escherichia coli / growth & development
  • Humans
  • In Vitro Techniques
  • Orthopedics*
  • Prostheses and Implants
  • Recombinant Proteins / administration & dosage*
  • Silanes
  • Surgical Wound Infection / prevention & control*
  • Titanium*
  • beta-Defensins / administration & dosage
  • beta-Defensins / pharmacology*

Substances

  • Antimicrobial Cationic Peptides
  • Coated Materials, Biocompatible
  • DEFB4A protein, human
  • Recombinant Proteins
  • Silanes
  • beta-Defensins
  • Collagen
  • Titanium